- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2024
- 93 Pages
Asia Pacific
From €2524EUR$2,655USD£2,120GBP
€2804EUR$2,950USD£2,356GBP
- Report
- January 2024
- 89 Pages
Europe
From €2524EUR$2,655USD£2,120GBP
€2804EUR$2,950USD£2,356GBP
- Report
- May 2023
- 237 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
The Single Cell Multi Omics market within the context of Proteomics is a rapidly growing field of research. It is focused on the analysis of proteins at the single cell level, allowing for a more detailed understanding of the molecular mechanisms of cellular processes. This technology is used to study a variety of biological processes, such as cell differentiation, cell signaling, and gene expression. It is also used to identify biomarkers for disease diagnosis and drug development.
Single Cell Multi Omics technology is used in a variety of research areas, including cancer, immunology, neuroscience, and stem cell research. It is also used in drug discovery and development, as well as in personalized medicine.
Some companies in the Single Cell Multi Omics market include 10x Genomics, Fluidigm, Illumina, NanoString Technologies, and Thermo Fisher Scientific. Show Less Read more